Circulating immune cell landscape in patients who had mild ischaemic stroke.
Young-Eun Cho, Hyangkyu Lee, Heekyong R Bae...
https://pubmed.ncbi.nlm.nih.gov/35264400/Actively Recruiting
Led by National Institutes of Health Clinical Center (CC) · Updated on 2026-11-03
5000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are conducting an observational study to collect and process blood components from healthy volunteer donors for use in laboratory research by NIH intramural investigators and FDA researchers. The study is designed to ensure donors meet specific eligibility criteria and fully understand the investigational nature of the research use of their donated blood, which will only be used for in vitro studies. Donors will be compensated according to the duration and discomfort of the donation, with protections and monitoring in place following federal regulatory standards. Participants who qualify will donate blood and blood components using standard phlebotomy and apheresis techniques. Requests for blood components for research require investigators to submit electronic memos describing the intended in vitro research, ensuring the samples are not used for in vivo studies. The study also includes detailed safety monitoring for repeat apheresis donors. Each blood component distributed is labeled with a unique product number, and the researchers maintain confidentiality linking donors to their products. During the study, donors will be consented with full explanation of risks and research use, and their donations will be tracked carefully. Researchers monitor safety frequently for repeat donors. The primary outcome measured is the provision of samples to researchers on a quarterly basis. The study involves ongoing blood collection and distribution for research purposes, with participant involvement including blood donation and safety assessments as needed.
CONDITIONS
COLLECT BLOOD/RESEARCH USE
S
Sandra Z Amamoo-Kakra
L
Leonard N Chen, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institutes of Health Clinical Center (CC)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Varies by participant
Participants donate blood or blood components through standard phlebotomy or apheresis techniques for research use.
Visits scheduled as needed for donation
Duration - Ongoing during participation
Repeat donors undergo frequent laboratory safety monitoring to ensure health and safety during the study.
Regular monitoring visits as required
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Young-Eun Cho, Hyangkyu Lee, Heekyong R Bae...
https://pubmed.ncbi.nlm.nih.gov/35264400/Kim Han, Komudi Singh, Matthew J Rodman...
https://pubmed.ncbi.nlm.nih.gov/33723462/Kumiko Nishio, Lise Pasquet, Kaddy Camara...
https://pubmed.ncbi.nlm.nih.gov/38127463/Jing Wu, Komudi Singh, Amy Lin...
https://pubmed.ncbi.nlm.nih.gov/35025762/D M Maynard, H F G Heijnen, W A Gahl...
https://pubmed.ncbi.nlm.nih.gov/20524979/Kim Han, Komudi Singh, Allison M Meadows...
https://pubmed.ncbi.nlm.nih.gov/37586364/Renee N Donahue, Lauren M Lepone, Italia Grenga...
https://pubmed.ncbi.nlm.nih.gov/28239472/Madeline Dahut, Kristen Fousek, Lucas A Horn...
https://pubmed.ncbi.nlm.nih.gov/37678915/Lucas A Horn, Paul L Chariou, Sofia R Gameiro...
https://pubmed.ncbi.nlm.nih.gov/35230974/Orit Jacobson, Hongwei H Zhang, Colleen P Olkowski...
https://pubmed.ncbi.nlm.nih.gov/40813232/National Institutes of Health Clinical Center (CC)
Lead Sponsor